Assessing Experiences With Hemophilia A and B: Patient and Caregiver Interviews
Phase 3
Completed
- Conditions
- Health Condition 1: D66- Hereditary factor VIII deficiency
- Registration Number
- CTRI/2021/08/035630
- Lead Sponsor
- Sanofi Aventis Groupe
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 14
Inclusion Criteria
Patients who had participated in phase 3 would be selected from 3 sites. By recruiting patients from multiple sites in India, it is anticipated that the interview substudy sample will be somewhat representative of the overall clinical trial population in India. No patient (or caregiver) clinical or demographic characteristics will be targeted during sample selection.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To know the experiences of patients who have participated in phase 3 clinical trialTimepoint: after 1 year of 1st recruitment
- Secondary Outcome Measures
Name Time Method To know the experiences of patients who have participated in phase 3 clinical trialTimepoint: after 1 year of 1st recruitment